Hepatic encephalopathy secondary to administra-tion of flutamide for prostate cancer;Encéphalopathie hépatique secondaire àla prise de flu t a mi de pour cancer de la prostate

Journal d'Urologie

Volumn 102, Issue 3, 1996, Pages 123-125

  Patel, H ^a   Rhee, E ^a   Zimmern, P H E ^b  

^a Kaiser Permanente ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Flutamide; Hepatic encephalopathy; Prostate cancer

Indexed keywords

FLUTAMIDE; LEUPRORELIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ARTICLE; CASE REPORT; HEPATIC ENCEPHALOPATHY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PROSTATE CANCER; ADENOCARCINOMA; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; PROSTATE TUMOR; REVIEW;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; DRUG THERAPY, COMBINATION; FLUTAMIDE; HEPATIC ENCEPHALOPATHY; HUMANS; LEUPROLIDE; MALE; PROSTATIC NEOPLASMS;

EID: 0029836143     PISSN: 02480018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. CORKERY SC, BlHRLE W, McCAFFREY JA, WHITCOMB FF, LEVY C, ELLIS R. Flutamide related fulminate hepatic failure [letter]. J Clin Gastroenterol 1991 ; 13 : 364-5.
2. CRAWFORD ED, EISENBERGER EA, McLEOD DG, SPAULDING JT, BENSON R, DORR A, BLUMENSTEIN BA, DAVIS MA, GOODMAN PJ. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. NEJM 1989 ; 321 : 419-24.
3. DANKOFFS J. Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer. J Uml 1992 ; 148 : 1914.
4. FARRELL CF. Drug-Induced Liver Disease. London, Churchill Livingstone. 1994, pp. 485-6.
5. FAU D, BERSON A, EUGENE D, FROMENTY B, FISCH C, PESSAYRE D. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. J Pharmacol Exp Ther 1992 ; 263 : 69-77.
6. GOMEZ J, DUPONT A. CUSAN L, TREMBLAY M, SUBURU R, LEMAY M, LABRIE F. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Amer J med 1992 ; 92 : 465-70.
7. HART W. STRICKER BHC. Flutamide and hepatitis [Letter]. Ann Int Med 1989; 10: 943-4.
8. JOHANSSON JE, ANDERSON SO, BECKMAN KW. LINGARDH G. ZADOR G. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate. Urologv 1987 ; 24: 55-9.
9. MOLLER S, IVERSON P, FRANZMANN M. Flutamide-induced liver failure. J Hepat 1990 ; 10 : 346-9.
10. NERI R, KASSEM N. Biological and clinical properties of antiandrogens. In ; BRECCIANI F, LIPPMAN ME and KING JFB, et al. eds. Progress in Cancer Research and Therapy. New York, Raven Press, 1985, 31 : 507-518.
11. SOGANI PC, VAGAIWALA MR, WHITMORE Jr WF. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy. Cancer 1984 ; 54 : 744-50.
12. WYSOWSKI DK, FREIMAN JP, TOURTLOT JB, HORION ML. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Int med 1993 : 118: 860-4.